Table 1.
Variable | Criteria | Respondents | Result |
---|---|---|---|
Age | Respondents in the USA aged <22 years | n = 3 | Removed from sample |
Progression status | Respondents without a response to progression (yes/no), but a response for date of progression | n = 13 | Progression marked “unknown” |
Respondents with a “yes” response to progression, but no response for date of progression | n = 34 | Progression marked “yes” | |
Respondents with a “no” response to progression, but with response for date of progression | n = 42 | Progression marked “unknown” | |
Other therapy | Respondents without a response to other GBM therapy (yes/no), but a response for date of initiation | n = 6 | Other therapy marked “unknown” |
Respondents with a “yes” response to other GBM therapy, but no response for date of initiation | n = 79 | Other therapy marked “yes” | |
Respondents with a “no” response to other GBM therapy, but with response for date of initiation | n = 7 | Other therapy marked “unknown” | |
Time since diagnosis | Respondents with a negative value for time since diagnosis | n = 1 | Time since diagnosis marked “unknown” |
Respondents with diagnosis year prior to date of birth | n = 1 | Time since diagnosis marked “unknown” | |
Time on TTFields | Patients with >9 years of time on TTFields | n = 5 | Time on TTFields marked “unknown” |
Patients with time on TTFields greater than or equal to time since diagnosis | n = 26 | Time on TTFields marked “unknown” |
TTFields, tumor treating fields.